Michael Bristow
Corporate Officer/Principal at University of Colorado Health Sciences Center
Net worth: 17 790 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Keuer | M | 65 | 18 years | |
| Robert Conway | M | 70 | 11 years | |
| C. Dekker | M | 60 | 3 years | |
| James Flynn | M | 43 | 2 years | |
| Jacob Ma-Weaver | M | 37 | 2 years | |
| Sharon Perry | F | - | 16 years | |
| Linda Grais | M | 68 | 17 years | |
| Anders Hove | M | 58 | 7 years | |
| Claude P. Selitrennikoff | M | 80 |
University of Colorado Health Sciences Center
| - |
| Richard Zane | M | - |
University of Colorado Health Sciences Center
| - |
| George Garmany | M | - |
University of Colorado Health Sciences Center
| - |
| Victor Renuart | M | 74 |
University of Colorado Health Sciences Center
| - |
| Stuart S. Kassan | M | - |
University of Colorado Health Sciences Center
| - |
| Lilly Marks | F | 76 |
University of Colorado Health Sciences Center
| - |
| Gilad S. Gordon | M | - |
University of Colorado Health Sciences Center
| - |
| John F. Carpenter | M | - |
University of Colorado Health Sciences Center
| - |
| Robin S. Heller | F | 58 |
University of Colorado Health Sciences Center
| - |
| David M. Strange | M | - |
University of Colorado Health Sciences Center
| - |
| William F. Jessee | M | - |
University of Colorado Health Sciences Center
| - |
| Richard R. Augspurger | M | - |
University of Colorado Health Sciences Center
| - |
| Richard L. Monfort | M | 70 |
University of Colorado Health Sciences Center
| - |
| Chantell Taylor | F | - |
University of Colorado Health Sciences Center
| 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Ozeroff | M | 65 |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 31 years |
| J. William Freytag | M | 72 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO.
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 13 years |
| Richard B. Brewer | M | 72 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 6 years |
| Brian L. Selby | M | 62 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 17 years |
| John L. Zabriskie | M | 85 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 8 years |
| Patrick M. Wheeler | M | 54 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 8 years |
| Burton E. Sobel | M | 86 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 9 years |
| Jean-Francois Formela | M | 67 | 7 years | |
| Dan Mitchell | M | 67 | 10 years | |
| Mary K. Pendergast | F | 73 | - | |
| Kathryn Falberg | F | 63 | - | |
| Ulrike Steinhorst | F | 72 | - | |
| Derek K. Cole | M | - | 3 years | |
| Raymond Woosley | M | 81 | 11 years | |
| Joseph Turner | M | 72 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 7 years |
| Andrew Dickinson | M | 54 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 2 years |
| David G. Lowe | M | 67 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 2 years |
| Reagan Ammann | M | - |
University of Colorado Health Sciences Center
| 4 years |
| David John York | M | - |
University of Colorado Health Sciences Center
| 2 years |
| Talley Scott | F | - |
University of Colorado Health Sciences Center
| 4 years |
| Robert Frederick Caspari | M | 78 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 1 years |
| Richard Yasenchak | M | - |
University of Colorado Health Sciences Center
| 4 years |
| William Hertlein | M | - |
University of Colorado Health Sciences Center
| 4 years |
| Jaime Modiano | M | - |
University of Colorado Health Sciences Center
| 8 years |
| Daniel J. Berberick | M | 63 |
University of Colorado Health Sciences Center
| 1 years |
| Matt Fordyce | M | - |
University of Colorado Health Sciences Center
| 4 years |
| Elizabeth Fogerty | F | - |
University of Colorado Health Sciences Center
| 4 years |
| Brian Kotzin | M | 74 |
University of Colorado Health Sciences Center
| 23 years |
| Craig Berman | M | - |
University of Colorado Health Sciences Center
| 3 years |
| Debra Marshall | M | - | 6 years | |
| Michael Berry | M | 59 | 4 years | |
| Susan Babcock | F | - |
University of Colorado Health Sciences Center
| 1 years |
| Ann Lenich Hards | M | - |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 10 years |
| Trisha Soares | F | - |
University of Colorado Health Sciences Center
| 4 years |
| Randall M. St. Laurent | M | 63 | - | |
| Sigrid van Bladel | M | - |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 2 years |
| Ian McNiece | M | 70 |
University of Colorado Health Sciences Center
| 5 years |
| Julian M. Goldman | M | 57 |
University of Colorado Health Sciences Center
| - |
| Judith Ann Hemberger | M | 77 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 1 years |
| Ted Love | M | 65 | 2 years | |
| Francis J. Bullock | M | 87 | 4 years | |
| John R. Julian | M | - |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 6 years |
| Laura Emery | F | - |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | - |
| Richard J. Gorczynski | M | - |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 8 years |
| Alan Nies | M | 86 |
University of Colorado Health Sciences Center
| 15 years |
| Lynne E. Weissberger | M | - |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | 1 years |
| James R. Carr | M | 61 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 2 years |
| Kirk Robert Dufty | M | - |
University of Colorado Health Sciences Center
| 4 years |
| Michael D. Lynch | M | - |
University of Colorado Health Sciences Center
| 3 years |
| Christopher Graybill | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 72 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Bristow
- Personal Network
